CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2023
Operating activities:
Net earnings	$ 824	$ 292	$ 161
Adjustments to reconcile net earnings to net cash provided by operations:
Depreciation and amortization	219	235	236
Stock-based compensation	81	74	73
Deferred income taxes	(18)	(100)	(149)
Loss on divestiture	112	238	0
Pension settlement charge	0	171	0
Goodwill, trademark and other asset impairments	0	0	445
Other	(26)	26	38
Changes in:
Receivables, net	(145)	(34)	(13)
Inventories, net	63	55	58
Prepaid expenses and other current assets	(9)	25	(1)
Accounts payable and accrued liabilities	(124)	(140)	157
Operating lease right-of-use assets and liabilities, net	2	0	1
Income taxes payable/prepaid	2	(147)	152
Net cash provided by operations	981	695	1,158
Investing activities:
Capital expenditures	(220)	(212)	(228)
Proceeds from divestiture, net of cash divested	128	17	0
Other	(2)	20	5
Net cash used for investing activities	(94)	(175)	(223)
Financing activities:
Notes and loans payable, net	0	(45)	(188)
Treasury stock purchased	(332)	0	0
Cash dividends paid to Clorox stockholders	(602)	(595)	(583)
Cash dividends paid to noncontrolling interests	(16)	(16)	(15)
Issuance of common stock for employee stock plans and other	26	1	33
Net cash used for financing activities	(924)	(655)	(753)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	0	(26)	0
Net increase (decrease) in cash, cash equivalents and restricted cash	(37)	(161)	182
Cash, cash equivalents and restricted cash:
Beginning of year	207	368	186
End of year	170	207	368
Supplemental cash flow information:
Interest paid	97	102	99
Income taxes paid, net of refunds	264	347	73
Noncash financing activities:
Cash dividends declared and accrued, but not paid	$ 16	$ 16	$ 16